ArticleAging2020

Could microtubule inhibitors be the best choice of therapy in gastric cancer with high immune activity: mutant DYNC1H1 as a biomarker.

Jin Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.